Apr 12, 2021 09:02 PM IST
Net Sales are expected to increase by 31 percent Y-o-Y (down 2.6 percent Q-o-Q) to Rs. 810.3 crore, according to Sharekhan.
- Apr 12, 2018 05:53 PM IST
Analysts predict the last quarter of FY18 to be mixed bag with revenues expected to remain almost flat to a growth of lower single digit on year-on-year basis. The net profit is predicted to decline by around 9-10 percent.
- Jan 18, 2018 08:36 AM IST
As Indian drug makers brace up to report their third quarter earnings in the days ahead, analysts predict Q3 FY18 to be mixed bag with revenues expected to remain flat on year-on-year basis, though on sequential basis things may look much better.
- Oct 31, 2017 04:11 PM IST
In an interview to CNBC-TV18, Shashank Sinha, Managing Director of Strides Shasun spoke about the results and his outlook for the company.
- Feb 07, 2017 02:30 PM IST
Going forward, the pharma company is going to to focus on its B2C business and the high cash generating verticals, he says.
- Oct 28, 2016 05:16 PM IST
In an interview to CNBC-TV18, Shashank Sinha, Group CEO of Strides Shasun spoke about the results and his outlook for the company.
- Aug 18, 2016 09:58 AM IST
In an interview to CNBC-TV18, Arun Kumar, Executive VC and MD of Strides Shasun said the company may sell off its API unit after enhancing its value.
- Aug 17, 2016 03:50 PM IST
Strides Shasun for the first quarter reported net profit at Rs 41.79 crore and total income stood at Rs 870 crore versus Rs 955 crore quarter on quarter.
- Aug 17, 2016 01:24 PM IST
CNBC-TV18‘s Ekta Batra talks about what to expect from Strides Shasun‘s numbers today.
- Jul 16, 2016 01:09 PM IST
Sales are expected to decrease by 4.7 percent Q-o-Q (up 58.3 percent Y-o-Y) to Rs 955.0 crore, according to Religare Research.
- May 16, 2016 04:14 PM IST
Third quarter performance was hit due to floods in Chennai but there has been a strong pullback in the last quarter, he said, adding growth in business from regulated markets like Australia and the US have helped, said Arun Kumar, Executive VC & MD at Strides Shasun.
- Feb 09, 2016 09:40 AM IST
The growth trajectory is very strong going forward and the company has all the necessary engines to grow the business at 20-25 percent CAGR, said Arun Kumar, MD, Strides Shasun.
- Jan 12, 2013 11:54 AM IST
Motilal Oswal has come out with its earnings estimates for pharmaceuticals sector for the quarter ended December 2012. The research firm expects the topline to grow by 22 percent, EBITDA by 21 percent on the back of strong operational performance by Ranbaxy, Glenmark, Strides, Torrent and Divi's.
- Apr 26, 2012 04:05 PM IST
Group CFO of Strides Arcolab TS Rangan tells CNBC-TV18 that the company is betting on Agila to drive growth in FY13.
- Apr 25, 2011 04:43 PM IST
Stride Arcolab has declared its first quarter results. The company's Q1 consolidated net profit was up 2.26% at Rs 40.7 crore versus Rs 39.8 crore. For 2011, he says, “A median EBITDA of 21% is the one we are looking at the increased sales of Rs 2,200 crore.”
- Apr 15, 2011 12:16 PM IST
Motilal Oswal has come out with its earning estimates on Pharmaceuticals sector for the quarter ended March 2011. According to the research firm, Strides Arcolab March quarter sales are expected to go up by 28.3% at Rs 479.1 crore, year-on-year, (YoY) basis.
- Feb 24, 2011 06:41 PM IST
Stride Arcolab announced it Q3 results for FY11. The company reported a consolidated net profit of Rs 122.4 crore for the year ended 2010 as against Rs 109.7 crore in previous year.